Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of IgPro20 (Hizentra) in PID
NCT01458171Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Apr 2011
- Primary completion
- Feb 2012
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Apr 2011; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT01458171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458171.